Carregant...
Therapy-activated stromal cells can dictate tumor fate
In this issue of JEM, Chan et al. describe a novel way by which an investigational form of chemotherapy known as low-dose metronomic chemotherapy can inhibit tumor growth, which also has therapeutic implications for targeting tumor-initiating cells (TICs), the tumor stroma, and chemokine receptors,...
Guardat en:
| Publicat a: | J Exp Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Rockefeller University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5154951/ https://ncbi.nlm.nih.gov/pubmed/27881735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20161845 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|